Science & Enterprise subscription

Follow us on Twitter

  • Many thanks @SciSeeker https://t.co/uQy4yl5pQb
    about 16 hours ago
  • New post on Science and Enterprise: Taking a Break https://t.co/QgH851GMZX #Science #Business
    about 4 days ago
  • Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000,… https://t.co/cGSC6j1Xl8
    about 4 days ago
  • New post on Science and Enterprise: Infographic – U.S. Venture Funds Near 20-Year Highs https://t.co/mIkraoGRAH #Science #Business
    about 4 days ago
  • A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially c… https://t.co/NHSLm9YBBG
    about 5 days ago

Please share Science & Enterprise

Hearing Loss Cell Therapy Licensed in $625M Deal

Man with headphones

A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma. . . . → Read More: Hearing Loss Cell Therapy Licensed in $625M Deal

Genentech, Biotech Partner on Multiple Sclerosis

Neurons illustration

A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech. . . . → Read More: Genentech, Biotech Partner on Multiple Sclerosis

Trial to Test App Alerting for Dementia-Linked Drugs

Phone and keyboard

A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer’s disease will soon be tested in a clinical trial. . . . → Read More: Trial to Test App Alerting for Dementia-Linked Drugs

Trial Shows Immunotherapies Extend Life with Melanoma

T-cell lymphocyte

First results from a clinical trial show a combination of immunotherapies extends survival among patients with melanoma, but shorter periods for other solid-tumor cancers. . . . → Read More: Trial Shows Immunotherapies Extend Life with Melanoma

Crispr Enhanced for RNA Editing

Feng Zhang

Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases. . . . → Read More: Crispr Enhanced for RNA Editing

Bacteria Recruited to Produce Graphene

Anne Meyer

Labs in the U.S. and the Netherlands developed techniques to sustainably produce high-quality graphene with more capabilities, using a strain of bacteria. . . . → Read More: Bacteria Recruited to Produce Graphene

Analysis – Most New Drugs Not Adding Patient Benefits

Tablet with charts

An analysis of drugs approved for use in Germany since 2011 shows no evidence most treatments provide new or added benefits to patients compared to standard care. . . . → Read More: Analysis – Most New Drugs Not Adding Patient Benefits

Voice Indicators to Monitor Dementia Progression

Brain circuits illustration

A company developing diagnostics for cognitive disorders from changes in speech patterns is partnering on vocal biomarkers to track progression of a form of dementia. . . . → Read More: Voice Indicators to Monitor Dementia Progression

Immunotherapy Biotech Gains $325M in Venture Funds

Investment graphic

A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $325M in Venture Funds

Blockchain Added to Clinical Trials Management

Blockchain network graphic

A contract research organization, or CRO, specializing in clinical trials is adding blockchain capability for data management, with help from an engineering consulting firm. . . . → Read More: Blockchain Added to Clinical Trials Management